ES2971091T3 - Un método para supervisar las respuestas farmacodinámicas mediadas por la administración de glucocorticoides in vivo - Google Patents
Un método para supervisar las respuestas farmacodinámicas mediadas por la administración de glucocorticoides in vivo Download PDFInfo
- Publication number
- ES2971091T3 ES2971091T3 ES18773895T ES18773895T ES2971091T3 ES 2971091 T3 ES2971091 T3 ES 2971091T3 ES 18773895 T ES18773895 T ES 18773895T ES 18773895 T ES18773895 T ES 18773895T ES 2971091 T3 ES2971091 T3 ES 2971091T3
- Authority
- ES
- Spain
- Prior art keywords
- glucocorticoid
- person
- gene signature
- administration
- signature score
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003862 glucocorticoid Substances 0.000 title claims abstract description 130
- 230000004044 response Effects 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims abstract description 30
- 238000001727 in vivo Methods 0.000 title abstract description 10
- 230000003285 pharmacodynamic effect Effects 0.000 title abstract description 9
- 230000001404 mediated effect Effects 0.000 title abstract description 4
- 229940037128 systemic glucocorticoids Drugs 0.000 claims abstract description 40
- 230000004547 gene signature Effects 0.000 claims description 93
- 229960005205 prednisolone Drugs 0.000 claims description 62
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 claims description 62
- 210000004369 blood Anatomy 0.000 claims description 53
- 239000008280 blood Substances 0.000 claims description 53
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims description 36
- 230000014509 gene expression Effects 0.000 claims description 34
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 24
- 101000919891 Homo sapiens Enoyl-CoA hydratase domain-containing protein 3, mitochondrial Proteins 0.000 claims description 19
- 101001076422 Homo sapiens Interleukin-1 receptor type 2 Proteins 0.000 claims description 16
- 101000799318 Homo sapiens Long-chain-fatty-acid-CoA ligase 1 Proteins 0.000 claims description 16
- 101000878253 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP5 Proteins 0.000 claims description 16
- 102100026017 Interleukin-1 receptor type 2 Human genes 0.000 claims description 16
- 102100033995 Long-chain-fatty-acid-CoA ligase 1 Human genes 0.000 claims description 16
- 102100030880 Enoyl-CoA hydratase domain-containing protein 3, mitochondrial Human genes 0.000 claims description 15
- 101000977768 Homo sapiens Interleukin-1 receptor-associated kinase 3 Proteins 0.000 claims description 15
- 102100023530 Interleukin-1 receptor-associated kinase 3 Human genes 0.000 claims description 15
- 101001077600 Homo sapiens Insulin receptor substrate 2 Proteins 0.000 claims description 14
- 102100025092 Insulin receptor substrate 2 Human genes 0.000 claims description 14
- 101100107081 Danio rerio zbtb16a gene Proteins 0.000 claims description 13
- 102100037573 Dual specificity protein phosphatase 12 Human genes 0.000 claims description 13
- 101000924017 Homo sapiens Dual specificity protein phosphatase 1 Proteins 0.000 claims description 13
- 101000881110 Homo sapiens Dual specificity protein phosphatase 12 Proteins 0.000 claims description 13
- 101100377226 Homo sapiens ZBTB16 gene Proteins 0.000 claims description 13
- 108700003766 Promyelocytic Leukemia Zinc Finger Proteins 0.000 claims description 13
- 102100040314 Zinc finger and BTB domain-containing protein 16 Human genes 0.000 claims description 13
- 102100037026 Peptidyl-prolyl cis-trans isomerase FKBP5 Human genes 0.000 claims description 12
- 102100021763 Alpha-mannosidase 2x Human genes 0.000 claims description 9
- 102100029595 Fatty acyl-CoA reductase 2 Human genes 0.000 claims description 9
- 102100028761 Heat shock 70 kDa protein 6 Human genes 0.000 claims description 9
- 101000615966 Homo sapiens Alpha-mannosidase 2x Proteins 0.000 claims description 9
- 101000917301 Homo sapiens Fatty acyl-CoA reductase 2 Proteins 0.000 claims description 9
- 101001078680 Homo sapiens Heat shock 70 kDa protein 6 Proteins 0.000 claims description 9
- 101000583616 Homo sapiens Polyhomeotic-like protein 2 Proteins 0.000 claims description 9
- 102100030903 Polyhomeotic-like protein 2 Human genes 0.000 claims description 9
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- 102100034799 CCAAT/enhancer-binding protein delta Human genes 0.000 claims description 5
- 102100038688 Cysteine-rich secretory protein LCCL domain-containing 2 Human genes 0.000 claims description 5
- 101000945965 Homo sapiens CCAAT/enhancer-binding protein delta Proteins 0.000 claims description 5
- 101000957715 Homo sapiens Cysteine-rich secretory protein LCCL domain-containing 2 Proteins 0.000 claims description 5
- 101000652382 Homo sapiens O-phosphoseryl-tRNA(Sec) selenium transferase Proteins 0.000 claims description 5
- 101000823949 Homo sapiens Serine palmitoyltransferase 2 Proteins 0.000 claims description 5
- 101000689199 Homo sapiens Src-like-adapter Proteins 0.000 claims description 5
- 101000596277 Homo sapiens TSC22 domain family protein 3 Proteins 0.000 claims description 5
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 claims description 5
- 102100022059 Serine palmitoyltransferase 2 Human genes 0.000 claims description 5
- 102100024519 Src-like-adapter Human genes 0.000 claims description 5
- 102100035260 TSC22 domain family protein 3 Human genes 0.000 claims description 5
- 102100024333 Toll-like receptor 2 Human genes 0.000 claims description 5
- 229960003957 dexamethasone Drugs 0.000 claims description 5
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims description 5
- 229960004618 prednisone Drugs 0.000 claims description 5
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 claims description 4
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 claims description 3
- VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 claims description 3
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 claims description 3
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 claims description 3
- 229960002537 betamethasone Drugs 0.000 claims description 3
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 claims description 3
- 229960004436 budesonide Drugs 0.000 claims description 3
- 229960004544 cortisone Drugs 0.000 claims description 3
- 229960002714 fluticasone Drugs 0.000 claims description 3
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 claims description 3
- 229960000890 hydrocortisone Drugs 0.000 claims description 3
- 229960004584 methylprednisolone Drugs 0.000 claims description 3
- 229960005294 triamcinolone Drugs 0.000 claims description 3
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 claims description 3
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 claims description 2
- 230000008859 change Effects 0.000 abstract description 3
- 230000002068 genetic effect Effects 0.000 abstract description 2
- 238000012544 monitoring process Methods 0.000 abstract description 2
- 239000003550 marker Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 description 40
- 102000003676 Glucocorticoid Receptors Human genes 0.000 description 35
- 108090000079 Glucocorticoid Receptors Proteins 0.000 description 35
- 101150002378 gC gene Proteins 0.000 description 17
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 14
- DZBKAUMYTFPJIS-HSZRJFAPSA-N n-ethyl-2-fluoro-n-methyl-4-[(5r)-5-[2-methyl-1-oxo-1-(1,3,4-thiadiazol-2-ylamino)propan-2-yl]-5h-chromeno[2,3-b]pyridin-2-yl]benzamide Chemical compound C1=C(F)C(C(=O)N(C)CC)=CC=C1C1=CC=C([C@@H](C=2C(=CC=CC=2)O2)C(C)(C)C(=O)NC=3SC=NN=3)C2=N1 DZBKAUMYTFPJIS-HSZRJFAPSA-N 0.000 description 14
- 210000005259 peripheral blood Anatomy 0.000 description 12
- 239000011886 peripheral blood Substances 0.000 description 12
- 229960003697 abatacept Drugs 0.000 description 11
- 238000000338 in vitro Methods 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 229940068196 placebo Drugs 0.000 description 9
- 239000000902 placebo Substances 0.000 description 9
- 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- NFBRIOXZUUCQFQ-JOCHJYFZSA-N 2-fluoro-n,n-dimethyl-4-[(5r)-5-[2-methyl-1-oxo-1-(1,3,4-thiadiazol-2-ylamino)propan-2-yl]-5h-chromeno[2,3-b]pyridin-2-yl]benzamide Chemical compound C1=C(F)C(C(=O)N(C)C)=CC=C1C1=CC=C([C@@H](C=2C(=CC=CC=2)O2)C(C)(C)C(=O)NC=3SC=NN=3)C2=N1 NFBRIOXZUUCQFQ-JOCHJYFZSA-N 0.000 description 8
- 230000002596 correlated effect Effects 0.000 description 8
- 239000004031 partial agonist Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 238000002487 chromatin immunoprecipitation Methods 0.000 description 7
- 210000000440 neutrophil Anatomy 0.000 description 7
- 101150044182 8 gene Proteins 0.000 description 6
- 238000004422 calculation algorithm Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 6
- 238000003753 real-time PCR Methods 0.000 description 6
- 150000003431 steroids Chemical class 0.000 description 6
- 102100020961 Actin-binding LIM protein 3 Human genes 0.000 description 5
- 102100036441 Amyloid-beta A4 precursor protein-binding family A member 2 Human genes 0.000 description 5
- 102100035631 Bloom syndrome protein Human genes 0.000 description 5
- 108091009167 Bloom syndrome protein Proteins 0.000 description 5
- 102100037677 Cell surface hyaluronidase Human genes 0.000 description 5
- 102100032263 DNA-directed RNA polymerase I subunit RPA49 Human genes 0.000 description 5
- 102100024821 Dynamin-binding protein Human genes 0.000 description 5
- 102100039639 E3 ubiquitin-protein ligase pellino homolog 1 Human genes 0.000 description 5
- 102100029003 Glucose-fructose oxidoreductase domain-containing protein 1 Human genes 0.000 description 5
- 102100040407 Heat shock 70 kDa protein 1B Human genes 0.000 description 5
- 102100031624 Heat shock protein 105 kDa Human genes 0.000 description 5
- 102100023357 Histone deacetylase complex subunit SAP30 Human genes 0.000 description 5
- 101000783819 Homo sapiens Actin-binding LIM protein 3 Proteins 0.000 description 5
- 101000928677 Homo sapiens Amyloid-beta A4 precursor protein-binding family A member 2 Proteins 0.000 description 5
- 101000880605 Homo sapiens Cell surface hyaluronidase Proteins 0.000 description 5
- 101001088155 Homo sapiens DNA-directed RNA polymerase I subunit RPA49 Proteins 0.000 description 5
- 101000909230 Homo sapiens Dynamin-binding protein Proteins 0.000 description 5
- 101000606708 Homo sapiens E3 ubiquitin-protein ligase pellino homolog 1 Proteins 0.000 description 5
- 101001059225 Homo sapiens Glucose-fructose oxidoreductase domain-containing protein 1 Proteins 0.000 description 5
- 101001037968 Homo sapiens Heat shock 70 kDa protein 1B Proteins 0.000 description 5
- 101000866478 Homo sapiens Heat shock protein 105 kDa Proteins 0.000 description 5
- 101000686001 Homo sapiens Histone deacetylase complex subunit SAP30 Proteins 0.000 description 5
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 5
- 101001091256 Homo sapiens Kinesin-like protein KIF13B Proteins 0.000 description 5
- 101000973157 Homo sapiens NEDD4 family-interacting protein 1 Proteins 0.000 description 5
- 101001098172 Homo sapiens P2X purinoceptor 5 Proteins 0.000 description 5
- 101000702391 Homo sapiens Protein sprouty homolog 1 Proteins 0.000 description 5
- 101000649073 Homo sapiens Protein-tyrosine sulfotransferase 1 Proteins 0.000 description 5
- 101001019136 Homo sapiens Putative methyltransferase-like protein 7A Proteins 0.000 description 5
- 101001060862 Homo sapiens Ras-related protein Rab-31 Proteins 0.000 description 5
- 101000692943 Homo sapiens Ribonuclease K6 Proteins 0.000 description 5
- 101000667595 Homo sapiens Ribonuclease pancreatic Proteins 0.000 description 5
- 101000665137 Homo sapiens Scm-like with four MBT domains protein 1 Proteins 0.000 description 5
- 101000836394 Homo sapiens Sestrin-1 Proteins 0.000 description 5
- 101000642258 Homo sapiens Spondin-2 Proteins 0.000 description 5
- 101000652482 Homo sapiens TBC1 domain family member 8 Proteins 0.000 description 5
- 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 5
- 102100034863 Kinesin-like protein KIF13B Human genes 0.000 description 5
- 102100037984 Mitoferrin-1 Human genes 0.000 description 5
- 102100022547 NEDD4 family-interacting protein 1 Human genes 0.000 description 5
- -1 NF-xB Proteins 0.000 description 5
- 102100037603 P2X purinoceptor 5 Human genes 0.000 description 5
- 102100030399 Protein sprouty homolog 1 Human genes 0.000 description 5
- 102100028081 Protein-tyrosine sulfotransferase 1 Human genes 0.000 description 5
- 102100034758 Putative methyltransferase-like protein 7A Human genes 0.000 description 5
- 102100027838 Ras-related protein Rab-31 Human genes 0.000 description 5
- 102100026386 Ribonuclease K6 Human genes 0.000 description 5
- 102100039832 Ribonuclease pancreatic Human genes 0.000 description 5
- 108091006469 SLC25A37 Proteins 0.000 description 5
- 102100038689 Scm-like with four MBT domains protein 1 Human genes 0.000 description 5
- 102100027288 Sestrin-1 Human genes 0.000 description 5
- 102100036427 Spondin-2 Human genes 0.000 description 5
- 102100030302 TBC1 domain family member 8 Human genes 0.000 description 5
- 102100038388 Vasoactive intestinal polypeptide receptor 1 Human genes 0.000 description 5
- 101710137655 Vasoactive intestinal polypeptide receptor 1 Proteins 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 231100000673 dose–response relationship Toxicity 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 239000000556 agonist Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229960004171 hydroxychloroquine Drugs 0.000 description 3
- XXSMGPRMXLTPCZ-UHFFFAOYSA-N hydroxychloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CCO)CC)=CC=NC2=C1 XXSMGPRMXLTPCZ-UHFFFAOYSA-N 0.000 description 3
- 238000002483 medication Methods 0.000 description 3
- 230000007115 recruitment Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000035903 transrepression Effects 0.000 description 3
- 238000010200 validation analysis Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 101150076076 64 gene Proteins 0.000 description 2
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 108010009992 CD163 antigen Proteins 0.000 description 2
- 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 230000004568 DNA-binding Effects 0.000 description 2
- 102100039556 Galectin-4 Human genes 0.000 description 2
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 2
- 101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 2
- 101001123331 Homo sapiens Peroxisome proliferator-activated receptor gamma coactivator 1-alpha Proteins 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- 208000005777 Lupus Nephritis Diseases 0.000 description 2
- 102100028960 Peroxisome proliferator-activated receptor gamma coactivator 1-alpha Human genes 0.000 description 2
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 2
- 241000219061 Rheum Species 0.000 description 2
- 102100025831 Scavenger receptor cysteine-rich type 1 protein M130 Human genes 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000010195 expression analysis Methods 0.000 description 2
- 238000010199 gene set enrichment analysis Methods 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 206010025135 lupus erythematosus Diseases 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- 229960004866 mycophenolate mofetil Drugs 0.000 description 2
- RTGDFNSFWBGLEC-SYZQJQIISA-N mycophenolate mofetil Chemical compound COC1=C(C)C=2COC(=O)C=2C(O)=C1C\C=C(/C)CCC(=O)OCCN1CCOCC1 RTGDFNSFWBGLEC-SYZQJQIISA-N 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 230000000770 proinflammatory effect Effects 0.000 description 2
- PUIBPGHAXSCVRF-QHFGJBOXSA-N prostaglandin C1 Chemical compound CCCCC[C@H](O)\C=C\C1=CCC(=O)[C@@H]1CCCCCCC(O)=O PUIBPGHAXSCVRF-QHFGJBOXSA-N 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000012353 t test Methods 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 101150054149 ANGPTL4 gene Proteins 0.000 description 1
- 102100036006 Adenosine receptor A3 Human genes 0.000 description 1
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
- 102100033830 Amphiphysin Human genes 0.000 description 1
- 102100022987 Angiogenin Human genes 0.000 description 1
- 102000045205 Angiopoietin-Like Protein 4 Human genes 0.000 description 1
- 108700042530 Angiopoietin-Like Protein 4 Proteins 0.000 description 1
- 102100022278 Arachidonate 5-lipoxygenase-activating protein Human genes 0.000 description 1
- 102100034691 Astrocytic phosphoprotein PEA-15 Human genes 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 1
- 102100037904 CD9 antigen Human genes 0.000 description 1
- 108090000835 CX3C Chemokine Receptor 1 Proteins 0.000 description 1
- 102100039196 CX3C chemokine receptor 1 Human genes 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102100032936 Carboxypeptidase M Human genes 0.000 description 1
- 108090000007 Carboxypeptidase M Proteins 0.000 description 1
- 102000009410 Chemokine receptor Human genes 0.000 description 1
- 108050000299 Chemokine receptor Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102100025877 Complement component C1q receptor Human genes 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 description 1
- 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 description 1
- 102100023582 Cyclic AMP-dependent transcription factor ATF-5 Human genes 0.000 description 1
- 102100039061 Cytokine receptor common subunit beta Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 102100029721 DnaJ homolog subfamily B member 1 Human genes 0.000 description 1
- 206010048474 Fat redistribution Diseases 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
- 102100037859 G1/S-specific cyclin-D3 Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 description 1
- 101000783645 Homo sapiens Adenosine receptor A3 Proteins 0.000 description 1
- 101000779845 Homo sapiens Amphiphysin Proteins 0.000 description 1
- 101000757236 Homo sapiens Angiogenin Proteins 0.000 description 1
- 101000755875 Homo sapiens Arachidonate 5-lipoxygenase-activating protein Proteins 0.000 description 1
- 101000734668 Homo sapiens Astrocytic phosphoprotein PEA-15 Proteins 0.000 description 1
- 101000738354 Homo sapiens CD9 antigen Proteins 0.000 description 1
- 101000933665 Homo sapiens Complement component C1q receptor Proteins 0.000 description 1
- 101000905746 Homo sapiens Cyclic AMP-dependent transcription factor ATF-5 Proteins 0.000 description 1
- 101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 description 1
- 101000866018 Homo sapiens DnaJ homolog subfamily B member 1 Proteins 0.000 description 1
- 101000866286 Homo sapiens Excitatory amino acid transporter 1 Proteins 0.000 description 1
- 101000738559 Homo sapiens G1/S-specific cyclin-D3 Proteins 0.000 description 1
- 101000926939 Homo sapiens Glucocorticoid receptor Proteins 0.000 description 1
- 101001071608 Homo sapiens Glutathione reductase, mitochondrial Proteins 0.000 description 1
- 101001076407 Homo sapiens Interleukin-1 receptor antagonist protein Proteins 0.000 description 1
- 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 description 1
- 101001027246 Homo sapiens Kynurenine 3-monooxygenase Proteins 0.000 description 1
- 101000917824 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-b Proteins 0.000 description 1
- 101001023037 Homo sapiens Myoferlin Proteins 0.000 description 1
- 101001059802 Homo sapiens N-formyl peptide receptor 3 Proteins 0.000 description 1
- 101000579484 Homo sapiens Period circadian protein homolog 1 Proteins 0.000 description 1
- 101001097889 Homo sapiens Platelet-activating factor acetylhydrolase Proteins 0.000 description 1
- 101000578474 Homo sapiens Polyunsaturated fatty acid lipoxygenase ALOX15B Proteins 0.000 description 1
- 101001126582 Homo sapiens Post-GPI attachment to proteins factor 3 Proteins 0.000 description 1
- 101001133936 Homo sapiens Prolyl 3-hydroxylase 2 Proteins 0.000 description 1
- 101000983140 Homo sapiens Protein associated with UVRAG as autophagy enhancer Proteins 0.000 description 1
- 101000878540 Homo sapiens Protein-tyrosine kinase 2-beta Proteins 0.000 description 1
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 description 1
- 101000633784 Homo sapiens SLAM family member 7 Proteins 0.000 description 1
- 101000617830 Homo sapiens Sterol O-acyltransferase 1 Proteins 0.000 description 1
- 101000798076 Homo sapiens T cell receptor delta constant Proteins 0.000 description 1
- 101000713602 Homo sapiens T-box transcription factor TBX21 Proteins 0.000 description 1
- 101000743488 Homo sapiens V-set and immunoglobulin domain-containing protein 4 Proteins 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 102100026018 Interleukin-1 receptor antagonist protein Human genes 0.000 description 1
- 102100026236 Interleukin-8 Human genes 0.000 description 1
- 102100037652 Kynurenine 3-monooxygenase Human genes 0.000 description 1
- 102100029205 Low affinity immunoglobulin gamma Fc region receptor II-b Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 101100013967 Mus musculus Gata3 gene Proteins 0.000 description 1
- 102100035083 Myoferlin Human genes 0.000 description 1
- 102100028130 N-formyl peptide receptor 3 Human genes 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 102000007399 Nuclear hormone receptor Human genes 0.000 description 1
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 102100025386 Oxidized low-density lipoprotein receptor 1 Human genes 0.000 description 1
- 102100028293 Period circadian protein homolog 1 Human genes 0.000 description 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 1
- 102000012335 Plasminogen Activator Inhibitor 1 Human genes 0.000 description 1
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 1
- 102100037518 Platelet-activating factor acetylhydrolase Human genes 0.000 description 1
- 206010036030 Polyarthritis Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 102100027921 Polyunsaturated fatty acid lipoxygenase ALOX15B Human genes 0.000 description 1
- 102100034015 Prolyl 3-hydroxylase 2 Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 102100026827 Protein associated with UVRAG as autophagy enhancer Human genes 0.000 description 1
- 102100037787 Protein-tyrosine kinase 2-beta Human genes 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 description 1
- 102100021269 Regulator of G-protein signaling 1 Human genes 0.000 description 1
- 101710140408 Regulator of G-protein signaling 1 Proteins 0.000 description 1
- 102100027611 Rho-related GTP-binding protein RhoB Human genes 0.000 description 1
- 101150054980 Rhob gene Proteins 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 102100029198 SLAM family member 7 Human genes 0.000 description 1
- 102000012977 SLC1A3 Human genes 0.000 description 1
- 108091006683 SLCO4A1 Proteins 0.000 description 1
- 206010058556 Serositis Diseases 0.000 description 1
- 102100022004 Solute carrier organic anion transporter family member 4A1 Human genes 0.000 description 1
- 101000697584 Streptomyces lavendulae Streptothricin acetyltransferase Proteins 0.000 description 1
- 102100032272 T cell receptor delta constant Human genes 0.000 description 1
- 102100036840 T-box transcription factor TBX21 Human genes 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 102000004398 TNF receptor-associated factor 1 Human genes 0.000 description 1
- 108090000920 TNF receptor-associated factor 1 Proteins 0.000 description 1
- 239000004012 Tofacitinib Substances 0.000 description 1
- 206010054094 Tumour necrosis Diseases 0.000 description 1
- 102100038296 V-set and immunoglobulin domain-containing protein 4 Human genes 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000012911 assay medium Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 229960002170 azathioprine Drugs 0.000 description 1
- LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 1
- 229960003270 belimumab Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000003081 coactivator Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 125000003306 cortisone group Chemical group 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000009274 differential gene expression Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000009266 disease activity Effects 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 238000003500 gene array Methods 0.000 description 1
- 238000011223 gene expression profiling Methods 0.000 description 1
- 108010009483 glucocorticoid receptor alpha Proteins 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000004179 hypothalamic–pituitary–adrenal axis Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000002998 immunogenetic effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 210000005210 lymphoid organ Anatomy 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000003012 network analysis Methods 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 238000001821 nucleic acid purification Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 208000030428 polyarticular arthritis Diseases 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 125000001897 prednisolone group Chemical group 0.000 description 1
- 150000003118 prednisones Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000008261 resistance mechanism Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 108091005418 scavenger receptor class E Proteins 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960003989 tocilizumab Drugs 0.000 description 1
- 229960001350 tofacitinib Drugs 0.000 description 1
- UJLAWZDWDVHWOW-YPMHNXCESA-N tofacitinib Chemical compound C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)C1=NC=NC2=C1C=CN2 UJLAWZDWDVHWOW-YPMHNXCESA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762551839P | 2017-08-30 | 2017-08-30 | |
| PCT/US2018/048240 WO2019046233A1 (en) | 2017-08-30 | 2018-08-28 | METHOD FOR MONITORING PHARMACODYNAMIC RESPONSES MEDIATED BY IN VIVO DELIVERY OF GLUCOCORTICOIDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2971091T3 true ES2971091T3 (es) | 2024-06-03 |
Family
ID=63678673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18773895T Active ES2971091T3 (es) | 2017-08-30 | 2018-08-28 | Un método para supervisar las respuestas farmacodinámicas mediadas por la administración de glucocorticoides in vivo |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11421278B2 (enExample) |
| EP (1) | EP3676402B1 (enExample) |
| JP (1) | JP7288431B2 (enExample) |
| KR (1) | KR102736851B1 (enExample) |
| CN (1) | CN111051534B (enExample) |
| ES (1) | ES2971091T3 (enExample) |
| WO (1) | WO2019046233A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113990486B (zh) * | 2021-10-27 | 2025-08-22 | 北京博富瑞医学检验实验室有限公司 | 一种基于aGVHD biomarker的一线糖皮质激素治疗反应预测模型 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002332573A1 (en) | 2001-08-17 | 2003-03-03 | Incyte Genomics, Inc. | Transporters and ion channels |
| US7384736B2 (en) * | 2001-09-06 | 2008-06-10 | Decode Genetics Ehf. | Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease |
| CN1193761C (zh) * | 2003-06-25 | 2005-03-23 | 暨南大学 | 一种糖皮质激素的可控释放体系及其制备方法 |
| SE0401032D0 (sv) * | 2004-04-22 | 2004-04-22 | Duocort Ab | A new acute glucocorticoid therapy |
| AU2005281352B2 (en) * | 2004-09-09 | 2011-01-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Liposomal compositions of glucocorticoid and glucocorticoid derivatives |
| CN103533943B (zh) | 2010-11-10 | 2018-02-13 | 安进研发（慕尼黑）股份有限公司 | 由cd3特异性结合结构域导致的不良作用的预防 |
| WO2013082288A1 (en) * | 2011-11-29 | 2013-06-06 | The Regents Of The University Of California | Glucorticoid receptor gene nr3c1 methylation in irritable bowel syndrome and other stress disorders |
-
2018
- 2018-08-28 KR KR1020207008663A patent/KR102736851B1/ko active Active
- 2018-08-28 EP EP18773895.0A patent/EP3676402B1/en active Active
- 2018-08-28 WO PCT/US2018/048240 patent/WO2019046233A1/en not_active Ceased
- 2018-08-28 CN CN201880056618.6A patent/CN111051534B/zh active Active
- 2018-08-28 JP JP2020512530A patent/JP7288431B2/ja active Active
- 2018-08-28 ES ES18773895T patent/ES2971091T3/es active Active
- 2018-08-28 US US16/642,060 patent/US11421278B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019046233A1 (en) | 2019-03-07 |
| US11421278B2 (en) | 2022-08-23 |
| US20200299770A1 (en) | 2020-09-24 |
| CN111051534A (zh) | 2020-04-21 |
| JP2020532302A (ja) | 2020-11-12 |
| EP3676402A1 (en) | 2020-07-08 |
| KR20200040872A (ko) | 2020-04-20 |
| JP7288431B2 (ja) | 2023-06-07 |
| EP3676402B1 (en) | 2023-12-27 |
| KR102736851B1 (ko) | 2024-11-29 |
| CN111051534B (zh) | 2025-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ahn et al. | Immune-inflammation gene signatures in endometriosis patients | |
| Brown et al. | Retinoic acid is essential for Th1 cell lineage stability and prevents transition to a Th17 cell program | |
| US11209440B2 (en) | T cell balance gene expression, compositions of matters and methods of use thereof | |
| JP5027209B2 (ja) | クローン病患者の末梢血白血球におけるＴ細胞受容体介在性腫瘍壊死因子スーパーファミリー及びケモカインのｍＲＮＡ発現の増強 | |
| Yu et al. | T cell–intrinsic function of the noncanonical NF-κB pathway in the regulation of GM-CSF expression and experimental autoimmune encephalomyelitis pathogenesis | |
| Hu et al. | Development of a molecular signature to monitor pharmacodynamic responses mediated by in vivo administration of glucocorticoids | |
| EP3266452A1 (en) | Means to treat myelomas which are resistant to thalidomide, lenalidomide or pomalidomide | |
| Lavu et al. | Clinical relevance of cytokines gene polymorphisms and protein levels in gingival cervical fluid from chronic periodontitis patients | |
| Garchow et al. | HIF-1α and miR-210 differential and lineage-specific expression in systemic lupus erythematosus | |
| Hosseini et al. | Upregulation of CD4+ T-cell derived MiR-223 in the relapsing phase of multiple sclerosis patients | |
| CN111593022B (zh) | vMIP-Ⅱ诱导CD8+ T细胞去磷酸化为Tcm及其在药物中的应用 | |
| Bordagaray et al. | CpG single-site methylation regulates TLR2 expression in proinflammatory PBMCs from apical periodontitis individuals | |
| Singh et al. | A molecular signature for CD8+ T cells from visceral leishmaniasis patients | |
| CN109996895A (zh) | 体外诊断精神障碍的方法和生物标志物 | |
| ES2971091T3 (es) | Un método para supervisar las respuestas farmacodinámicas mediadas por la administración de glucocorticoides in vivo | |
| Li et al. | Decreased expression of IL-33 in immune thrombocytopenia | |
| AU2018230346B2 (en) | Hypoxic NK cells and methods therefor | |
| Rodríguez-Carrio et al. | TNFα polymorphism as marker of immunosenescence for rheumatoid arthritis patients | |
| US20170003277A1 (en) | Biological characterization of a glatiramer acetate related drug product using mammalian and human cells | |
| US20150285823A1 (en) | Compositions and methods related to dormant senescence-prone cells (dspc) | |
| Zhou et al. | Identification of immune-related genes and small-molecule drugs in hypertension-induced left ventricular hypertrophy based on machine learning algorithms and molecular docking | |
| Rawat et al. | Genomics links inflammation with neurocognitive impairment in children living with human immunodeficiency virus type-1 | |
| Galoppin et al. | CITE-seq reveals inhibition of NF-κB pathway in B cells from vitamin D-treated multiple sclerosis patients | |
| Nsingwane et al. | Inhibition of the complement pathway induces Cellular Proliferation and Migration in Pancreatic Ductal Adenocarcinoma | |
| JP6726278B2 (ja) | 薬物アレルギー反応の起因薬物を同定するための方法及びキット |